{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "decreases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:P07327",
      "entity_text" : "ADH1",
      "entity_type" : "protein"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uniprot:P41180",
      "entity_text" : "CASR",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "CASR loss- or gain-of-function mutations cause familial hypocalciuric hypercalcemia type 1 (FHH1) or autosomal dominant hypocalcemia type 1 (ADH1), respectively, but the population prevalence of FHH1 or ADH1 is unknown.",
  "reading_complete" : "2020-08-08T12:14:33Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-08T12:08:27Z",
  "trigger" : "cause",
  "evidence" : [ "CASR loss- or gain-of-function mutations cause familial hypocalciuric hypercalcemia type 1 (FHH1) or autosomal-dominant hypocalcemia type 1 (ADH1" ],
  "pmc_id" : "7273533",
  "score" : 0
}